Latest News and Press Releases
Want to stay updated on the latest news?
-
Following approval from the Danish Competition and Consumer Authority, Erik Lytzen A/S is now part of InstallatørGruppen. Erik Lytzen A/S is a multidisciplinary installation company headquartered in...
-
SERB Pharmaceuticals has completed the acquisition of development and commercialization rights to Idefirix (imlifidase) in Europe
-
1 Billion Cryptocurrency Token Position Acquired in DeFi Development Corp.’s (Nasdaq: DFDV) $DONT DisclaimerCoinThe $DONT DisclaimerCoin transaction creates DFDV's first meme coin partnership,...
-
PROVIDENCE, R.I., July 01, 2026 (GLOBE NEWSWIRE) -- via IBN -- Beeline Holdings, Inc. (NASDAQ: BLNE) ("Beeline" or the "Company"), a technology-driven mortgage and title platform, today announced...
-
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
SOLANA BEACH, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating...
-
Viridien A French société anonymewith a share capital of € 7,219,747Registered office: 27 avenue Carnot, 91300 Massy, FranceEvry Trade and Companies Register 969 202 241 Information on the total...
-
8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Nes Ziona, Israel, July 01, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics (“AME”) for...